ERBB2 and neoplasm: Previous studies using Neu and PyMT models predicted a key role for the E2F1 transcription factor through a pathway signature analysis, suggesting that mechanisms outside the overexpression of the Neu or PyMT oncogene were contributing to tumor biology7,8.